A Yeast RNA-Interference Pesticide Targeting the Irx Gene Functions as a Broad-Based Mosquito Larvicide and Adulticide.
Keshava MysoreLonghua SunLimb K HapairaiChien-Wei WangJessica IgiedeJoseph B RoetheleNicholas D ScheelMax P ScheelPing LiNa WeiDavid W SeversonMolly Duman-ScheelPublished in: Insects (2021)
Concerns for widespread insecticide resistance and the unintended impacts of insecticides on nontarget organisms have generated a pressing need for mosquito control innovations. A yeast RNAi-based insecticide that targets a conserved site in mosquito Irx family genes, but which has not yet been identified in the genomes of nontarget organisms, was developed and characterized. Saccharomyces cerevisiae constructed to express short hairpin RNA (shRNA) matching the target site induced significant Aedes aegypti larval death in both lab trials and outdoor semi-field evaluations. The yeast also induced high levels of mortality in adult females, which readily consumed yeast incorporated into an attractive targeted sugar bait (ATSB) during simulated field trials. A conserved requirement for Irx function as a regulator of proneural gene expression was observed in the mosquito brain, suggesting a possible mode of action. The larvicidal and adulticidal properties of the yeast were also verified in Aedes albopictus, Anopheles gambiae, and Culexquinquefasciatus mosquitoes, but the yeast larvicide was not toxic to other nontarget arthropods. These results indicate that further development and evaluation of this technology as an ecofriendly control intervention is warranted, and that ATSBs, an emerging mosquito control paradigm, could potentially be enriched through the use of yeast-based RNAi technology.
Keyphrases
- aedes aegypti
- saccharomyces cerevisiae
- zika virus
- dengue virus
- gene expression
- dna methylation
- transcription factor
- diabetic rats
- randomized controlled trial
- air pollution
- genome wide
- oxidative stress
- risk factors
- white matter
- particulate matter
- gram negative
- cancer therapy
- wastewater treatment
- drug induced
- cardiovascular events
- copy number
- endothelial cells
- multidrug resistant